IRCT2016031827097N1已完成2 期
Compare of orlistat and metformin in the treatment of fatty liver disease in non-diabetic patients
Ardebil University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •( Having Nonalcoholic fatty liver disease, the absence of diabetes mellitus, Fatty liver grade 2 and above, not having severe systemic disease, Lack of viral and autoimmune hepatitis, Lack of thyroid disease, do not have hyper triglyceridemia and Exclusion criteria: Having severe systemic disease, having viral hepatitis and autoimmune, having thyroid disease, Hyper triglyceridemia)
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) PatientsObesityNCT01003483Yazd Research & Clinical Center for Infertility80
已完成
不适用
Comparison of therapeutic effects of metformin and simvastatin in PCOSPCOS.Polycystic ovarian syndromeIRCT201012285487N2Alzahra Hospital Research Center60
已完成
不适用
Effect of metformin, pioglitazone and vitaminE E in patients with non-alcoholic fatty liver diseasenon-alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedIRCT2016010411991N3Vice chancellor for research,Kermanshah University of Medical Sciences93
招募中
3 期
empagliflozin effect in polycystic ovarian syndromPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20220822055771N1Shahre-kord University of Medical Sciences50
招募中
4 期
A clinical trial involving patients with Polycystic Ovary Syndrome and to compare the effectivess of Metformin and oral contraceptives given alone or in combination to these patients.CTRI/2019/06/019879SMHS Hospital Srinagar